Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06232512 · ClinicalTrials.gov registry record · NA
Multimodal Haptic Feedback for Plantar Sensory Substitution
A NA study of Hypoesthesia, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06232512: Recruiting NA study of Hypoesthesia, sponsored by Shirley Ryan AbilityLab.
NCT06232512 is a NA study of Hypoesthesia that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06232512, a NA study of Hypoesthesia, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will explore the use of a haptic device for sensory substitution in individuals with a movement disorder that has caused loss of plantar sensation. The haptic device consists of two components. The first element is a flexible insole with embedded pressure-sensing elements that transmit the spatial patterns of applied foot pressure over time. The second element is a haptic receiver with embedded actuators that vibrate or heat up in proportion to the transmitted pressure patterns, thus substituting the patient's lost plantar sensation.
Conditions Studied
Interventions
- DEVICE Haptic Device
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06232512
The ClinicalTrials.gov registry entry for NCT06232512 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypoesthesia appearing as the primary indexed condition, and to 1 intervention - of which Haptic Device is the first listed.
NCT06232512 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06232512 about?
NCT06232512 is a clinical study titled "Multimodal Haptic Feedback for Plantar Sensory Substitution". The study will explore the use of a haptic device for sensory substitution in individuals with a movement disorder that has caused loss of plantar sensation. The haptic device consists of two components. The first element is a flexible insole with embedded pressure-sensing elements that transmit the...
What is the current status of trial NCT06232512?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-20. Estimated completion is 2026-12-01.
What conditions does trial NCT06232512 study?
This clinical trial studies the following conditions: Hypoesthesia.
What interventions are being tested in trial NCT06232512?
The interventions under investigation include: Haptic Device (DEVICE).
Who is sponsoring clinical trial NCT06232512?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06232512 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.